References
- 1Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: Data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390:2549–2558. DOI: 10.1016/S0140-6736(17)32478-9
- 2Mohammadian Khonsari N, Shahrestanaki E, Ejtahed HS, et al. Long-term trends in hypertension prevalence, awareness, treatment, and control rate in the Middle East and North Africa: A systematic review and meta-analysis of 178 population-based studies. Curr Hypertens Rep. 2021;23:
41 . DOI: 10.1007/s11906-021-01159-0 - 3Fan Z, Yang C, Zhang J, et al. Trends and influence factors in the prevalence, awareness, treatment, and control of hypertension among US adults from 1999 to 2018. PLoS One. 2023;18:
e0292159 . DOI: 10.1371/journal.pone.0292159 - 4Aviles-Santa ML, Monroig-Rivera A, Soto-Soto A, Lindberg NM. Current state of diabetes mellitus prevalence, awareness, treatment, and control in Latin America: Challenges and innovative solutions to improve health outcomes across the continent. Curr Diab Rep. 2020;20:
62 . DOI: 10.1007/s11892-020-01341-9 - 5Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013–2018. JAMA. 2021;326:2498–2506. DOI: 10.1001/jama.2021.22208
- 6Elmaleh-Sachs A, Schwartz JL, Bramante CT, et al. Obesity management in adults: A review. JAMA. 2023;330:2000–2015. DOI: 10.1001/jama.2023.19897
- 7Laouali N, Shah S, MacDonald CJ, et al. BMI in the associations of plant-based diets with type 2 diabetes and hypertension risks in women: The E3N prospective cohort study. J Nutr. 2021;151:2731–2740. DOI: 10.1093/jn/nxab158
- 8Ouyang X, Lou Q, Gu L, et al. Anthropometric parameters and their associations with cardio-metabolic risk in Chinese working population. Diabetol Metab Syndr. 2015;7:
37 . DOI: 10.1186/s13098-015-0032-5 - 9Benabdelkamel H, Masood A, Okla M, Al-Naami MY, Alfadda AA. A proteomics-based approach reveals differential regulation of urine proteins between metabolically healthy and unhealthy obese patients. Int J Mol Sci. 2019;20. DOI: 10.3390/ijms20194905
- 10Du Z, Zhu W, Zhao Y, et al. The epidemic of stroke mortality attributed to high body mass index in mainland China: Current trends and future prediction. Front Public Health. 2022;10:
1021646 . DOI: 10.3389/fpubh.2022.1021646 - 11Lin H, Xiao N, Lin S, Liu M, Liu GG. Associations of hypertension, diabetes and heart disease risk with body mass index in older Chinese adults: A population-based cohort study. BMJ Open. 2024;14:
e083443 . DOI: 10.1136/bmjopen-2023-083443 - 12Lip S, Jeemon P, McCallum L, et al. Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes. Eur Heart J. 2016;37:968–974. DOI: 10.1093/eurheartj/ehv557
- 13Bruno RM, Taddei S. New-onset diabetes in hypertensive patients and mortality: Timing is everything. Eur Heart J. 2016;37:975–977. DOI: 10.1093/eurheartj/ehv594
- 14Gupta AK, Dahlof B, Dobson J, et al. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication. Diabetes Care. 2008;31:982–988. DOI: 10.2337/dc07-1768
- 15Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350–357. DOI: 10.1056/NEJM198708063170605
- 16Kahn BB. Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance. Cell. 1998;92:593–596. DOI: 10.1016/S0092-8674(00)81125-3
- 17Boarescu PM, Boarescu I, Pop RM, et al. Evaluation of oxidative stress biomarkers, pro-inflammatory cytokines, and histological changes in experimental hypertension, dyslipidemia, and type 1 diabetes mellitus. Int J Mol Sci. 2022;23. DOI: 10.3390/ijms23031438
- 18Li H, Shi Z, Chen X, et al. Relationship between obesity indicators and hypertension-diabetes comorbidity in an elderly population: A retrospective cohort study. BMC Geriatr. 2023;23:
789 . DOI: 10.1186/s12877-023-04510-z - 19Wu W, Wu Y, Yang J, et al. Relationship between obesity indicators and hypertension-diabetes comorbidity among adults: A population study from Central China. BMJ Open. 2022;12:
e052674 . DOI: 10.1136/bmjopen-2021-052674 - 20Chen C, Lu FC, Department of Disease Control Ministry of Health PRC. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17Suppl:1–36.
- 21Hageman SHJ, Dorresteijn JAN, Pennells L, et al. The relevance of competing risk adjustment in cardiovascular risk prediction models for clinical practice. Eur J Prev Cardiol. 2023;30:1741–1747. DOI: 10.1093/eurjpc/zwad202
- 22Lipsky AM, Greenland S. Causal directed acyclic graphs. JAMA. 2022;327:1083–1084. DOI: 10.1001/jama.2022.1816
- 23Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:1037–1057. DOI: 10.1002/sim.3841
- 24Hirani V, Zaninotto P, Primatesta P. Generalised and abdominal obesity and risk of diabetes, hypertension and hypertension-diabetes co-morbidity in England. Public Health Nutr. 2008;11:521–527. DOI: 10.1017/S1368980007000845
- 25Russo C, Jin Z, Homma S, et al. Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease. Eur J Heart Fail. 2010;12:454–461. DOI: 10.1093/eurjhf/hfq022
- 26Izzo R, de Simone G, Trimarco V, et al. Hypertensive target organ damage predicts incident diabetes mellitus. Eur Heart J. 2013;34:3419–3426. DOI: 10.1093/eurheartj/eht281
- 27Zuloaga KL, Johnson LA, Roese NE, et al. High fat diet-induced diabetes in mice exacerbates cognitive deficit due to chronic hypoperfusion. J Cereb Blood Flow Metab. 2016;36:1257–1270. DOI: 10.1177/0271678X15616400
- 28Shen XM, Huang YQ, Zhang XY, et al. Association between dietary patterns and prediabetes risk in a middle-aged Chinese population. Nutr J. 2020;19:
77 . DOI: 10.1186/s12937-020-00593-1 - 29He Y, Li Y, Yang X, et al. The dietary transition and its association with cardiometabolic mortality among Chinese adults, 1982–2012: a cross-sectional population-based study. Lancet Diabetes Endocrinol. 2019;7:540–548. DOI: 10.1016/S2213-8587(19)30152-4
- 30Kornitzer M, Dramaix M, De Backer G. Epidemiology of risk factors for hypertension: Implications for prevention and therapy. Drugs. 1999;57:695–712. DOI: 10.2165/00003495-199957050-00003
- 31Gelber RP, Gaziano JM, Manson JE, Buring JE, Sesso HD. A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens. 2007;20:370–377. DOI: 10.1016/j.amjhyper.2006.10.011
- 32Patel SA, Ali MK, Alam D, et al. Obesity and its relation with diabetes and hypertension: A cross-sectional study across 4 geographical regions. Glob Heart. 2016;11:71–79.e74. DOI: 10.1016/j.gheart.2016.01.003
- 33Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3:280–287. DOI: 10.1001/jamacardio.2018.0022
- 34Shihab HM, Meoni LA, Chu AY, et al. Body mass index and risk of incident hypertension over the life course: The Johns Hopkins Precursors Study. Circulation. 2012;126:2983–2989. DOI: 10.1161/CIRCULATIONAHA.112.117333
- 35van Oort S, Beulens JWJ, van Ballegooijen AJ, Grobbee DE, Larsson SC. Association of cardiovascular risk factors and lifestyle behaviors with hypertension: A mendelian randomization study. Hypertension. 2020;76:1971–1979. DOI: 10.1161/HYPERTENSIONAHA.120.15761
- 36Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017;122:1–7. DOI: 10.1016/j.phrs.2017.05.013
- 37Hall JE, Mouton AJ, da Silva AA, et al. Obesity, kidney dysfunction, and inflammation: Interactions in hypertension. Cardiovasc Res. 2021;117:1859–1876. DOI: 10.1093/cvr/cvaa336
- 38Chandrasekaran P, Weiskirchen R. The role of obesity in type 2 diabetes mellitus-an overview. Int J Mol Sci. 2024;25. DOI: 10.3390/ijms25031882
- 39Caleyachetty R, Barber TM, Mohammed NI, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: A population-based cohort study. Lancet Diabetes Endocrinol. 2021;9:419–426. DOI: 10.1016/S2213-8587(21)00088-7
- 40Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490:55–60. DOI: 10.1038/nature11450
- 41Ling C, Bacos K, Ronn T. Epigenetics of type 2 diabetes mellitus and weight change – a tool for precision medicine? Nat Rev Endocrinol. 2022;18:433–448. DOI: 10.1038/s41574-022-00671-w
- 42Tang ML, Zhou YQ, Song AQ, et al. The relationship between body mass index and incident diabetes mellitus in Chinese aged population: A cohort study. J Diabetes Res. 2021;2021:
5581349 . DOI: 10.1155/2021/5581349 - 43Hu Y, Bhupathiraju SN, de Koning L, Hu FB. Duration of obesity and overweight and risk of type 2 diabetes among US women. Obesity (Silver Spring). 2014;22:2267–2273. DOI: 10.1002/oby.20851
- 44Bays HE, Chapman RH, Grandy S. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: Comparison of data from two national surveys. Int J Clin Pract. 2007;61:737–747. DOI: 10.1111/j.1742-1241.2007.01336.x
- 45Cao C, Hu H, Zheng X, et al. Association between central obesity and incident diabetes mellitus among Japanese: A retrospective cohort study using propensity score matching. Sci Rep. 2022;12:
13445 . DOI: 10.1038/s41598-022-17837-1 - 46Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021;137:
111315 . DOI: 10.1016/j.biopha.2021.111315 - 47Sharma AM, Chetty VT. Obesity, hypertension and insulin resistance. Acta Diabetol. 2005;42 Suppl 1:S3–8. DOI: 10.1007/s00592-005-0175-1
- 48Xu X, Mishra GD, Dobson AJ, Jones M. Progression of diabetes, heart disease, and stroke multimorbidity in middle-aged women: A 20-year cohort study. PLoS Med. 2018;15:
e1002516 . DOI: 10.1371/journal.pmed.1002516 - 49Pantell MS, Prather AA, Downing JM, Gordon NP, Adler NE. Association of social and behavioral risk factors with earlier onset of adult hypertension and diabetes. JAMA Netw Open. 2019;2:
e193933 . DOI: 10.1001/jamanetworkopen.2019.3933 - 50Wang L, Gao P, Zhang M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. JAMA. 2017;317:2515–2523. DOI: 10.1001/jama.2017.7596
- 51Chen S, Si Y, Hanewald K, et al. Disease burden of ageing, sex and regional disparities and health resources allocation: A longitudinal analysis of 31 provinces in Mainland China. BMJ Open. 2022;12:
e064641 . DOI: 10.1136/bmjopen-2022-064641 - 52Luo F, Huang Y, Jiang L, Fan Q, Gou Z. Ethnic disparities and temporal trends in health resource allocation: A retrospective decadal analysis in Sichuan, a multi-ethnic Province of Southwest China (2009–2019). BMC Health Serv Res. 2024;24:
541 . DOI: 10.1186/s12913-024-11036-6